You have 9 free searches left this month | for more free features.

no evidence of diseae activity (NEDA)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neurofilaments for NEDA Assessing in MS

Terminated
  • Multiple Sclerosis
  • London, England, United Kingdom
    Queen Mary University of London
Feb 9, 2022

Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,

Terminated
  • Relapsing-Remitting Multiple Sclerosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Hamburg, Germany
  • +1 more
Mar 1, 2022

Silent Progression Activity Monitoring - SPAM Study

Not yet recruiting
  • Multiple Sclerosis
  • NO INTERVENTION
  • Nice, France
    CHU de Nice
Dec 5, 2022

Cancer Survivor, Central Obesity, No Evidence of Disease Trial in Los Angeles (other, behavioral, device)

Withdrawn
  • Cancer Survivor
  • +2 more
  • Best Practice
  • +5 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 15, 2020

Multiple Sclerosis, Relapsing-Remitting Trial in Amsterdam (Ocrelizumab)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VU
Apr 21, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Switzerland (serum Neurofilament Filament Light chain (sNfL) monitoring)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • serum Neurofilament Filament Light chain (sNfL) monitoring
  • Basel, Basel Stadt, Switzerland
  • +7 more
Oct 17, 2023

Behavior, Child, Physical Inactivity Trial in Istanbul (Intervention group)

Recruiting
  • Behavior, Child
  • Physical Inactivity
  • Intervention group
  • Istanbul, Turkey
    Istanbul University-Cerrahpasa
Dec 28, 2022

Chronic Disease, Exercise, Physical Activity Trial in Greenville (Invitation to adopt)

Recruiting
  • Chronic Disease
  • +2 more
  • Invitation to adopt
  • Greenville, South Carolina
    Prisma Health
Oct 2, 2023

Kesimpta® in Swiss Multiple Sclerosis Patients -Observational

Recruiting
  • Multiple Sclerosis
  • Ofatumumab
  • Baden, Aargau, Switzerland
  • +17 more
Jan 20, 2023

Ofatumumab in Portuguese Multiple Sclerosis Patients

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • (no location specified)
Mar 30, 2023

Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae

Recruiting
  • Batten Disease
  • CLN6
  • Natural history
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 20, 2022

Hernia Incisional, Exercise Trial in Germany, Switzerland (Physiotherapy)

Recruiting
  • Hernia Incisional
  • Exercise
  • Physiotherapy
  • Koblenz, Germany
  • +4 more
Nov 7, 2022

Interstitial Lung Disease Trial in Istanbul (Exercise)

Recruiting
  • Interstitial Lung Disease
  • Exercise
  • Istanbul, Turkey
    İstanbul Faculty of Medicine
Oct 13, 2023

Physical Activity, Exercise, Acute Leukemia Trial in Chapel Hill, Durham (Build Stamina Program)

Completed
  • Physical Activity
  • +4 more
  • Build Stamina Program
  • Chapel Hill, North Carolina
  • +1 more
Sep 22, 2022

Childhood Obesity, Physical Activity Trial in Taif (I'm an Active Hero (IAAH) Intervention Program)

Not yet recruiting
  • Childhood Obesity
  • Physical Activity
  • I'm an Active Hero (IAAH) Intervention Program
  • Taif, Maccha, Saudi Arabia
    General Administration of Education in Taif-KSA
Mar 1, 2023

Cardiovascular Diseases, Obesity Trial in Saint Louis (PREVENT tool, Wait-list Control)

Completed
  • Cardiovascular Diseases
  • Obesity
  • PREVENT tool
  • Wait-list Control
  • Saint Louis, Missouri
    Washington University in St. Louis
Nov 7, 2023

Urinary Incontinence Trial in Ottawa (Pessary Intervention, Tampon Intervention)

Not yet recruiting
  • Urinary Incontinence
  • Pessary Intervention
  • Tampon Intervention
  • Ottawa, Ontario, Canada
    McLean Function Measurement Lab
Mar 6, 2023

Multiple Sclerosis, Relapsing-Remitting, Caloric Restriction Trial in Pozzilli (Caloric restriction, Caloric restriction without

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Caloric Restriction
  • Caloric restriction
  • Caloric restriction without cow's milk and gluten
  • Pozzilli, IS, Italy
    Neuromed - Istituto Neurologico Mediterraneo Pozzilli
Jul 26, 2022

Multiple Sclerosis Trial in France (DMT withdrawal, DMT continuation)

Recruiting
  • Multiple Sclerosis
  • DMT withdrawal
  • DMT continuation
  • Angers, France
  • +22 more
Mar 25, 2022

Sarcoma Trial in Guangzhou (chidamide and toripalimab)

Recruiting
  • Sarcoma
  • chidamide and toripalimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 4, 2022

Stress Urinary Incontinence, Patient Satisfaction, Surgery Trial in Great Neck (No activity restrictions, Activity restrictions)

Completed
  • Stress Urinary Incontinence
  • +2 more
  • No activity restrictions
  • Activity restrictions
  • Great Neck, New York
    North Shore University Hospital
Feb 2, 2023

Relapse Remitting Multiple Sclerosis Trial in United States (Ofatumumab)

Recruiting
  • Relapse Remitting Multiple Sclerosis
  • Chandler, Arizona
  • +16 more
Jan 13, 2023

Aging Trial (Adjusted Cognitive-biased modification task, Cognitive-biased modification task)

Not yet recruiting
  • Aging
  • Adjusted Cognitive-biased modification task
  • Cognitive-biased modification task
  • (no location specified)
Jan 26, 2023

Aging Trial in Chicago (BAILAMOS™ @home/en casa, ¡En Forma y Fuerte! @home/en casa)

Not yet recruiting
  • Aging
  • BAILAMOS™ @home/en casa
  • ¡En Forma y Fuerte! @home/en casa
  • Chicago, Illinois
    University of Illinois at Chicago
Oct 18, 2022

Obesity Trial in Lexington, Chapel Hill (Enhanced Go NAPSACC, Basic Go NAPSACC)

Active, not recruiting
  • Obesity
  • Enhanced Go NAPSACC
  • Basic Go NAPSACC
  • Lexington, Kentucky
  • +1 more
Oct 25, 2022